Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.
from Business News https://ift.tt/7Kbeli5
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
February 01, 2024
0
